Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches
Frontiers in Pharmacology · 17.06.2026 · 17
DOI: 10.3389/fphar.2026.1810887 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.06.2026. Verfasst von Mili Prajapati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Parul Institute of Applied Science, Faculty of Applied Sciences, Parul University, Vadodara, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis is a life-threatening condition characterized by simultaneous hyperinflammation and immunosuppression, which leads to organ dysfunction and mortality. It is a global health concern, which is estimated to be approximately 166 million cases and 21.4 million global deaths in 2021.
Aim
This review aimed to analyze sepsis epidemiology, pathophysiology, current therapeutic approaches and challenges, and assess the transformational role of modern therapeutic approaches, including precision medicine, and Artificial Intelligence (AI)/Machine Learning (ML) in sepsis. Methodology A literature search was carried out across multiple databases, including PubMed, Web of Science, and Scopus. The search was focused on hyperinflammation, immunosuppression in sepsis, current therapy, and future advances.
Result
The review integrated the search data from original articles, review papers, and clinical trials. After careful analysis, we observed that the efficacy of current therapy is limited due to the heterogeneity of sepsis patients, the lack of patient selection based on immune status, timing, and validated biomarkers. Precision methods based on classifying patient genotypes and multi-omics-based biomarkers suggest a potential approach to risk stratification and therapeutic guidance. Concurrently, AI/ML models exhibit improved predictive accuracy and early clinical diagnosis, facilitating early identification and risk stratification.
Conclusion
The integration of AI/ML and precision medicine into sepsis care has the potential to reduce mortality in clinically significant endotypes and allow focused immunomodulatory treatments fulfilling Sustainable Development Goal 3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Science, Parul Institute of Applied Science, Faculty of Applied Sciences, Parul University, Vadodara, India.
- Department of Applied Science and Humanities, Parul Institute of Technology, Parul University, Vadodara, India.
- Autoimmunity and Inflammation Program, Hospital for Special Surgery at Weill Cornell Medicine, New York, NY, United States.
Zitieren
APA
Prajapati, M., Singh, V., Mishra, A., Khatua, D., Rana, M., & Jyoti, A. (2026). Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1810887
Vancouver
Prajapati M, Singh V, Mishra A, Khatua D, Rana M, Jyoti A. Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1810887
BibTeX
@article{Prajapati2026,
author = {Prajapati, Mili and Singh, Vaishnavi and Mishra, Akash and Khatua, Debnarayan and Rana, Minakshi and Jyoti, Anupam},
title = {Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1810887}
}
EUVIMED